Newbridge Financial Services Group’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-107
| Closed | -$6.23K | – | 1102 |
|
|
2024
Q4 | $6.23K | Buy |
+107
| New | +$6.23K | ﹤0.01% | 832 |
|
|
2024
Q3 | – | Sell |
-106
| Closed | -$5.96K | – | 861 |
|
|
2024
Q2 | $5.96K | Sell |
106
-1,673
| -94% | -$94.1K | ﹤0.01% | 808 |
|
|
2024
Q1 | $104K | Sell |
1,779
-1,232
| -41% | -$72.2K | 0.05% | 284 |
|
|
2023
Q4 | $162K | Sell |
3,011
-1,773
| -37% | -$95.7K | 0.08% | 216 |
|
|
2023
Q3 | $232K | Sell |
4,784
-705
| -13% | -$34.2K | 0.12% | 175 |
|
|
2023
Q2 | $310K | Sell |
5,489
-151
| -3% | -$8.53K | 0.15% | 139 |
|
|
2023
Q1 | $304K | Buy |
5,640
+231
| +4% | +$12.5K | 0.16% | 137 |
|
|
2022
Q4 | $284K | Sell |
5,409
-991
| -15% | -$52.1K | 0.16% | 133 |
|
|
2022
Q3 | $302K | Sell |
6,400
-120
| -2% | -$5.66K | 0.18% | 125 |
|
|
2022
Q2 | $329K | Sell |
6,520
-1,267
| -16% | -$63.9K | 0.2% | 106 |
|
|
2022
Q1 | $475K | Sell |
7,787
-304
| -4% | -$18.5K | 0.23% | 92 |
|
|
2021
Q4 | $533K | Buy |
8,091
+1,189
| +17% | +$78.3K | 0.25% | 82 |
|
|
2021
Q3 | $433K | Buy |
6,902
+4,742
| +220% | +$297K | 0.27% | 87 |
|
|
2021
Q2 | $130K | Buy |
2,160
+756
| +54% | +$45.5K | 0.08% | 234 |
|
|
2021
Q1 | $77K | Buy |
1,404
+198
| +16% | +$10.9K | 0.06% | 300 |
|
|
2020
Q4 | $66K | Buy |
1,206
+282
| +31% | +$15.4K | 0.05% | 274 |
|
|
2020
Q3 | $46K | Buy |
+924
| New | +$46K | 0.05% | 334 |
|